65597-0504 VANFLYTA - CanMED: NDC

Product NDC:

65597-0504

Brand Name:

VANFLYTA

Generic Name:

QUIZARTINIB

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: QUIZARTINIB DIHYDROCHLORIDE

Strength: 17.7

Unit: mg/1

Packages:

Code: 65597-0504-04

Description: 1 BOTTLE in 1 CARTON (65597-504-04) / 14 TABLET, FILM COATED in 1 BOTTLE

Effective Date: July 20, 2023

Discontinued:

Code: 65597-0504-28

Description: 1 BOTTLE in 1 CARTON (65597-504-28) / 28 TABLET, FILM COATED in 1 BOTTLE

Effective Date: July 20, 2023

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

FLT3

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox